Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
IL37 Biologics Sequence Review Report 2026: Interleukin-37 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL37 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL34 Biologics Sequence Review Report 2026: Interleukin-34 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL34 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL27 Biologics Sequence Review Report 2026: Interleukin-27 subunit alpha Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
IL26 Biologics Sequence Review Report 2026: Interleukin-26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL25 Biologics Sequence Review Report 2026: Interleukin-25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL24 Biologics Sequence Review Report 2026: Interleukin-24 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL24 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL20 Biologics Sequence Review Report 2026: Interleukin-20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL1F10 Biologics Sequence Review Report 2026: Interleukin-1 family member 10 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL1F10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL19 Biologics Sequence Review Report 2026: Interleukin-19 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL17D Biologics Sequence Review Report 2026: Interleukin-17D Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL17D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL17C Biologics Sequence Review Report 2026: Interleukin-17C Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL17C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL17B Biologics Sequence Review Report 2026: Interleukin-17B Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL17B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
251
252
253
254
255
>>
1670
>